Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Petróleo Brasileiro SA (PBR) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance

Petróleo Brasileiro SATrade
Zimmer Biomet Holdings IncTrade

Price performance (Past 24H)

Key statistics

Petróleo Brasileiro SA vs Zimmer Biomet Holdings Inc — how do they compare? Petróleo Brasileiro SA trades at $25.53 (market cap $151.94B), while Zimmer Biomet Holdings Inc trades at $89.66 (market cap $16.95B). The key difference: Petróleo Brasileiro SA is far larger — about 9× Zimmer Biomet Holdings Inc's market cap, and Petróleo Brasileiro SA pays the higher dividend (6.79%). Which is the better fit depends on your goals — on Pluang, investors hold Petróleo Brasileiro SA for 25 Days and Zimmer Biomet Holdings Inc for 89 Days on average.

PBRZBH
Market Cap
$151.94B$16.95B
Volume
30,240,0922,505,240
Sector
EnergyHealth
52-Week High
$24.69$103.98
52-Week Low
$11.54$79.58
Typical Hold Time
25 Days89 Days
Enterprise Value
$212.36B$24.02B
Dividend Yield
6.79%1.08%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Petróleo Brasileiro SA

Petrobras (PBR) is trading at $25.16, up 4.88% with strong bullish momentum. The stock shows robust fundamentals with a P/E of 6.24, net margin of 24.52%, and positive earnings surprises in recent quarters. Recent news highlights new oil discoveries and production growth initiatives, while technical indicators show overbought conditions with RSI above 80.

PBR offers attractive valuation metrics and strong profitability, but faces risks from political interference and commodity price volatility. Analyst consensus leans bullish with 50% buy ratings, though the current price exceeds the $22.33 consensus target. The company's expansion projects and LNG deals provide long-term growth catalysts.

Zimmer Biomet Holdings Inc

Zimmer Biomet (ZBH) trades at $88.49, down 1.33% today, with a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $2.07 surpassing the $2.01 estimate. Revenue growth is steady, reaching $8.23B in 2025, though net income margin has moderated to 9.48%. A quarterly dividend of $0.24 was declared, payable in October 2026. Analyst consensus price target is $103.11, implying potential upside from current levels.

The outlook is mixed: solid fundamentals and earnings momentum support long-term value, but technical weakness and elevated debt levels pose near-term risks. Investment appeal hinges on execution of commercial transformation and robotics adoption offsetting competitive pressures. Key risks include margin compression and macroeconomic sensitivity affecting procedure volumes.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

PBR
74% Buy26% Sell
Avg holding period · 25 Days
ZBH
100% Buy0% Sell
Avg holding period · 89 Days

Top news

Latest headlines on both assets

About Petróleo Brasileiro SA

Petróleo Brasileiro S.A., commonly known as Petrobras, is a state-controlled Brazilian multinational corporation in the oil and gas industry. The company is one of the world's largest producers of oil and gas, primarily operating in exploration, production, refining, and power generation. Petrobras is particularly known for its deep-sea and ultra-deep-sea exploration and production activities in the vast pre-salt offshore reserves, which are a major component of Brazil's economy.

Read more on PBR →

About Zimmer Biomet Holdings Inc

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.

Read more on ZBH →